Fumarate propofol tenofovir tablets (Vemlidy) are a novel antiviral drug primarily used for the treatment of chronic hepatitis B virus infection, characterized by strong targeting and high safety.

1. Main indications

(1) Suitable for chronic hepatitis B patients over 12 years old and weighing ≥ 35kg.

(2) Long term antiviral therapy for patients with compensatory liver disease.

2 Characteristics of applicable population

(1) Suitable for patients with chronic hepatitis B who are HBV DNA positive.

(2) Can be used for antiviral therapy in both newly diagnosed and treated patients.

3 Treatment Objectives

(1) It can inhibit the replication of hepatitis B virus and reduce the level of HBV DNA.

(2) Improve the degree of liver inflammation and fibrosis.

4. Use by special groups

(1) Patients with renal insufficiency need to adjust their dosage.

(2) HIV co infected individuals need to combine other antiviral drugs.